Review Article

Preventive Transhepatic Tract Embolisation after Percutaneous Biliary Interventions: A Systematic Review

Table 2

Techniques of preventive transhepatic tract embolisation, technical success, and embolisation-related adverse events graded according to the CIRSE classification.

Embolic agentAuthor/yearTechnique of transhepatic tract embolisationTechnical success (%)Embolisation-related adverse events (%)

CyanoacrylateSchmitz-R 2000NBCA and iodised oil (50 : 50); injected through a 3F-PTFE-catheter; 7F-or 9F-port20/20 (100.0%)0/20 (0.0%)
Lyon 2006NBCA and iodised oil (50 : 50); injected through an 8F-dilator catheter21/21 (100.0%)0/20 (0.0%)
Seif 2013NBCA and iodised oil (80 : 20); injected through a 6F-dilator catheter24/25 (96.0%)Glue migration: CIRSE 3°: 1/25 (4.0%)
Hwang 2019NBCA/iodised oil (50 : 50; 40 : 60; 33 : 66), autologous blood, injected through an 8/14F-dilator catheter41/42 (97.6%)1/42 (2.4%) glue migration: CIRSE 1°, pain: 8/42 (19.0%)
GelatinDale 2015Gelatin foam pledgets, 14G/2 cm length, 2-3, one with radiopaque marker, push rod stylet, 8F-port92/92 (100.0%)0/92 (0.0%)
Augustin 2019Gelatin sponge torpedoes, manually prepared, delivered by pushing catheter/flushing, 8/11F-port97/98 (98.9%)0/98 (0.0%)
CoilsSofue 2012Metallic coils: 1–3 (5 mm × 5 cm; 4 mm × 3 cm; 3 mm × 4 cm); 6.5F-port16/16 (100.0%)0/16 (0.0%)
All311/314 (99.0%)10/314 (3.2%)